Cargando…
Primary care physician attitudes and perceptions of the impact of FDA-proposed REMS policy on prescription of extended-release and long-acting opioids
With increasing numbers of patients experiencing chronic pain, opioid therapy is becoming more common, leading to increases in concern about issues of abuse, diversion, and misuse. Further, the US Food and Drug Administration recently released a statement notifying sponsors and manufacturers of exte...
Autores principales: | Salinas, Gregory D, Robinson, Caroline O, Abdolrasulnia, Maziar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474156/ https://www.ncbi.nlm.nih.gov/pubmed/23091393 http://dx.doi.org/10.2147/JPR.S35798 |
Ejemplares similares
-
Improving the physician-patient cardiovascular risk dialogue to improve statin adherence
por: Casebeer, Linda, et al.
Publicado: (2009) -
Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events
por: Doroodchi, Hamidreza, et al.
Publicado: (2008) -
Update on prescription extended-release opioids and appropriate patient selection
por: Brennan, Michael J
Publicado: (2013) -
Communication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patterns
por: Glauser, Terry A, et al.
Publicado: (2011) -
Advancing regulatory science and assessment of FDA REMS programs: A mixed-methods evaluation examining physician survey response
por: Brewer, Sarah E., et al.
Publicado: (2019)